Old asthma drug may help kids with rare genetic condition
NCT ID NCT03029429
Summary
This study is testing whether theophylline, a medication historically used for asthma, can help children and young adults with pseudohypoparathyroidism. This rare genetic disorder causes early obesity, short stature, and increased diabetes risk. Researchers will give participants either theophylline or a placebo for one year to see if it helps with weight loss and blood sugar control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOHYPOPARATHYROIDISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ashley Shoemaker
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.